Through excellence in cancer research, education, and community engagement, the Partnership between the University of Puerto Rico and the University of Texas MD Anderson Cancer Center aims to reduce health disparities derived from infection-driven malignancies in Texas and Puerto Rico, and increase the number of Hispanics pursuing careers in cancer research.

Contacts

PMB 371 PO Box 70344 San Juan, PR 00936-8344

uprmdacc@upr.edu

(787)-772-8300 Exts. (1119, 1150)

Infection-driven Malignancy
Program for Advancing Careers and Translational Sciences (IMPACT)
Dear Researchers and students: the UPR/MD Anderson partnership is available if you seek research training, and/or need research space, materials, or support. Please contact us so that we can help you achieve your career and research goals.

MISSION


Through excellence in cancer research, education, and community engagement, the Partnership between the University of Puerto Rico and the University of Texas MD Anderson Cancer Center aims to reduce health disparities derived from infection-driven malignancies in Texas and Puerto Rico, and increase the number of Hispanics pursuing careers in cancer research.

// News Events

News and events

For those interested in having their proposal internally reviewed prior to submission to their funding opportunity, we are again offering the INTEREST service.

Important Dates and instructions:

1. April 29, 2022:

– Submit (1) Intent Form (attached) and (2) pdf copies of the abstract of the grant INTEREST@mdanderson.org and maria.gonzalez9@upr.edu

2. May 2, 2022: Full Application Submission Deadline

– Please submit a single PDF that includes the proposal: abstract, aims, significance, innovation, research strategies, references, biosketch of PI and other key personnel (the standard NIH format except the budget pages)

3. May 13, 2022 – INTEREST Review Meeting

– The INTEREST study section will review grants

Congratulations!

The UPR/ MD Anderson Partnership is proud to announce that Joseph Barnes has been awarded a Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (F31). The title of his study is “Novel Role of Peroxisome Proliferator Activated Receptor Beta/Delta in X-Linked Adrenoleukodystrophy” (Award # F31NS124110).

Congratulations!

The UPR/ MD Anderson Partnership is proud to announce that Maria Gonzalez-Pons has been awarded an AACR Minority & Minority-Serving Institution Faculty Scholar in Cancer Research Award to attend AACR Annual Meeting 2022 which will take place April 8-13, 2022, in New Orleans, LA. The title of her poster presentation is “Host-Genetic susceptibility to COVID-19 and pandemic-associated stressors”.

Congratulations!

The UPR/ MD Anderson Cancer Center partnership is proud to announce that Axel Gierbolini Bermudez has been awarded a Minority Scholar in Cancer Research Award for the14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved taking place October 6-8, 2021. The title of his virtual presentation is: Impact of COVID19 public policies on utilization of cervical cancer screening in Puerto Rico during March 15, 2020, to July 31, 2020.

+
graduate students
+
undergraduate students
+
MD students
+
Research papers in 5 years
// UPRMDACC - Partnership

Our Institutions

MD Anderson Cancer Center
Medical Sciences Campus at UPR
// UPRMDACC

Collaborators